ArticleRheumatology (Oxford, England)2025

Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis.

Andreu Fernández-Codina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.